ald403 migraineAgricultural BiotechnologyUpdated on Jan 2, 2020 View more like this | Visit SHIRLEY, NY | Contact Bella Smith |

Recombinant Humanized monoclonal antibody expressed in CHO binding to Human CGRP. ALD403 is a novel monoclonal antibody targeted to calcitonin gene-related peptide, or CGRP, for migraine prevention. CGRP is a validated target that is believed to play a key role in migraine.